Category Archives: Business and Investments

Latest From Business and Investments

Company Presentations and Partnering Opens

The list of more than 300 companies invited to present at the 2008 BIO International Convention’s Business Forum can now be accessed at http://www.bio2008.org/businessforum.  Check it out! Participants in the Business Forum will also have the opportunity to schedule one-on-one partnering meetings. Find out more at (you guessed it!) http://www.bio2008.org/businessforum.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

2008 BIO International Convention Show Daily

The Scientist, our trade publication partner for the daily newsletter at the convention, has extended their editorial submission deadline to April 30th. To submit newsworthy content, go to www.the-scientist.com/bio/index/ . Submit something today!  

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Record number of institutional investors at CEO

The final numbers are in and we have good reason to celebrate (perhaps we should get a three-day weekend?!) - there were a record number of institutional investors at the CEO & Investor Conference, 1,050 in total. Most of the more than 200 company presentations were full rooms, since in total we had more than 2000 participants. And obviously a lot of dealmaking and potential dealmaking was in the works with more than 1400 one-on-one meetings.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Duck taped to the side of a train

Despite a delayed train, I got home at 11:30 last night, not too bad considering how bad it could have been! At least the thirty minute delay allowed me to hang out with Mary from Amtrak who repeatedly got requests from folks trying to move up their reservations and she had the pleasure of turning them away one after another since all the trains were filled to the brim. At least she offered them all Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

From Fuel to Food to Fashion

Industrial biotech does it all. The Third Wave in biotech is looking bright for the future. Industrial biotech represents the confluence of market demand and the potential for market solution, according to David Berry, MD, PhD of Flagship Ventures – one of the panel speakers. Synthetic biotechnology, for one, is enabling the next generation in biofuels, while companies like Mascoma are commercializing cellulosic ethanol.  The future vision for industrial biotech is to have a significant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: